Pages that link to "Item:Q1430337"
From MaRDI portal
The following pages link to Hopf point analysis for angiogenesis models (Q1430337):
Displaying 22 items.
- Dynamics of a data based ovarian cancer growth and treatment model with time delay (Q330562) (← links)
- Angiogenesis model with Erlang distributed delays (Q335233) (← links)
- The nature of Hopf bifurcation for the Gompertz model with delays (Q409877) (← links)
- On an extension of a mathematical model for tumor anti-angiogenesis (Q425828) (← links)
- Time delay in physiological systems: analyzing and modeling its impact (Q427083) (← links)
- Vascular phenotype identification and anti-angiogenic treatment recommendation: a pseudo-multiscale mathematical model of angiogenesis (Q738575) (← links)
- Analysis of the Hopf bifurcation for the family of angiogenesis models. II: The case of two nonzero unequal delays (Q902503) (← links)
- On dynamic tumor eradication conditions under combined chemical/anti-angiogenic therapies (Q1709157) (← links)
- Chemotherapy of vascularised tumours: role of vessel density and the effect of vascular ``pruning'' (Q1716206) (← links)
- Simulation of tumor response to immunotherapy using a hybrid cellular automata model (Q1788276) (← links)
- Optimal and suboptimal protocols for a class of mathematical models of tumor anti-angiogenesis (Q1794472) (← links)
- Tumour eradication by antiangiogenic therapy: analysis and extensions of the model by Hahnfeldt et al. (1999) (Q1886332) (← links)
- A three-dimensional angiogenesis model with time-delay (Q2099192) (← links)
- Optimal control with isoperimetric constraint for chemotherapy of tumors (Q2170964) (← links)
- The role of mechanical host-tumour interactions in the collapse of tumour blood vessels and tumour growth dynamics (Q2194985) (← links)
- On the role of endothelial progenitor cells in tumor neovascularization (Q2196791) (← links)
- What mathematical models can or cannot do in glioma description and understanding (Q2206309) (← links)
- A bi-parametric model for the tumour angiogenesis and antiangiogenesis therapy (Q2390073) (← links)
- Modeling the VEGF-Bcl-2-CXCL8 pathway in intratumoral agiogenesis (Q2426395) (← links)
- Intensified Doxorubicin-Based Regimen Efficacy in Residual Non-Hodgkin's Lymphoma Disease: Towards a Computationally Supported Treatment Improvement (Q2788513) (← links)
- Tumor Development Under Combination Treatments with Anti-angiogenic Therapies (Q2820388) (← links)
- Tractable Model of Malignant Gliomas Immunotherapy with Discrete Time Delays (Q4628548) (← links)
